Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Silcox

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Research Square|April 1, 2024
Preventing Overdoses Involving Stimulants: The POINTS Study ProtocolJaclyn Hughto, Josiah Rich, Patrick Kelly, et al.
Drug and Alcohol Dependence Reports|September 27, 2023
Trends and correlates of abscess history among people who inject drugs in Massachusetts: A mixed methods exploration of experiences amidst a rapidly evolving drug supplyLeah M Benrubi, Joseph Silcox, Jaclyn Hughto, et al.
SSM. Qualitative Research in Health|June 25, 2025
Self-reported pathways through which illicitly manufactured fentanyl enters the stimulant supply: Novel insights from people incarcerated for drug manufacturing and distributionPatrick J A Kelly, Stephanie A Vento, Traci C Green, et al.
Harm Reduction Journal|August 18, 2025
Correction: Developing a comprehensive inventory to define harm reduction housingSofia Zaragoza, Joseph Silcox, Sabrina Rapisarda, et al.
Harm Reduction Journal|January 24, 2025
Developing a comprehensive inventory to define harm reduction housingSofia Zaragoza, Joseph Silcox, Sabrina Rapisarda, et al.
Health & Justice|June 24, 2026
Contrasting perspectives and applications of the Good Samaritan Overdose Prevention Law: insights from people who use and distribute drugs in Rhode IslandJoseph Silcox, David Pletta, Jaclyn M W Hughto, et al.
Journal of the American Pharmacists Association : Japha|October 20, 2023
Pharmacy staff-reported adaptations to naloxone provision and over-the-counter (OTC) syringe sales during the COVID-19 pandemic: Experiences across multiple states and 2 pharmacy chainsTraci C Green, Joseph Silcox, Derek Bolivar, et al.
Research in Social & Administrative Pharmacy : RSAP|February 23, 2024
"I go out of my way to give them an extra smile now:" A study of pharmacists who participated in Respond to Prevent, a community pharmacy intervention to accelerate provision of harm reduction materialsAdriane N Irwin, Mary Gray, Daniel Ventricelli, et al.
Substance Use & Addiction Journal|June 24, 2025
Study Protocol on Rapid Measurement of Novel Harm Reduction Housing on HIV Risk, Treatment Uptake, Drug Use, and SupplyTraci C Green, Joseph Silcox, Sofia Zaragoza, et al.
Substance Abuse Treatment, Prevention, and Policy|May 22, 2023
Drug use patterns and factors related to the use and discontinuation of medications for opioid use disorder in the age of fentanyl: findings from a mixed-methods study of people who use drugsJaclyn M W Hughto, Abigail Tapper, Sabrina S Rapisarda, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Research Square|April 1, 2024
Preventing Overdoses Involving Stimulants: The POINTS Study ProtocolJaclyn Hughto, Josiah Rich, Patrick Kelly, et al.
Drug and Alcohol Dependence Reports|September 27, 2023
Trends and correlates of abscess history among people who inject drugs in Massachusetts: A mixed methods exploration of experiences amidst a rapidly evolving drug supplyLeah M Benrubi, Joseph Silcox, Jaclyn Hughto, et al.
SSM. Qualitative Research in Health|June 25, 2025
Self-reported pathways through which illicitly manufactured fentanyl enters the stimulant supply: Novel insights from people incarcerated for drug manufacturing and distributionPatrick J A Kelly, Stephanie A Vento, Traci C Green, et al.
Harm Reduction Journal|August 18, 2025
Correction: Developing a comprehensive inventory to define harm reduction housingSofia Zaragoza, Joseph Silcox, Sabrina Rapisarda, et al.
Harm Reduction Journal|January 24, 2025
Developing a comprehensive inventory to define harm reduction housingSofia Zaragoza, Joseph Silcox, Sabrina Rapisarda, et al.
Health & Justice|June 24, 2026
Contrasting perspectives and applications of the Good Samaritan Overdose Prevention Law: insights from people who use and distribute drugs in Rhode IslandJoseph Silcox, David Pletta, Jaclyn M W Hughto, et al.
Journal of the American Pharmacists Association : Japha|October 20, 2023
Pharmacy staff-reported adaptations to naloxone provision and over-the-counter (OTC) syringe sales during the COVID-19 pandemic: Experiences across multiple states and 2 pharmacy chainsTraci C Green, Joseph Silcox, Derek Bolivar, et al.
Research in Social & Administrative Pharmacy : RSAP|February 23, 2024
"I go out of my way to give them an extra smile now:" A study of pharmacists who participated in Respond to Prevent, a community pharmacy intervention to accelerate provision of harm reduction materialsAdriane N Irwin, Mary Gray, Daniel Ventricelli, et al.
Substance Use & Addiction Journal|June 24, 2025
Study Protocol on Rapid Measurement of Novel Harm Reduction Housing on HIV Risk, Treatment Uptake, Drug Use, and SupplyTraci C Green, Joseph Silcox, Sofia Zaragoza, et al.
Substance Abuse Treatment, Prevention, and Policy|May 22, 2023
Drug use patterns and factors related to the use and discontinuation of medications for opioid use disorder in the age of fentanyl: findings from a mixed-methods study of people who use drugsJaclyn M W Hughto, Abigail Tapper, Sabrina S Rapisarda, et al.
Pageof 3